Goldman Sachs Resumes Biogen (BIIB) at Conviction Buy on Upcoming Drug Launches

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. MRNA
2. KLAR
3. KEYS
4. PANW
5. SPY
6. MRK
7. HD
8. DVLT
9. NBIS
10. MRCY

Go back to Goldman Sachs Resumes Biogen (BIIB) at Conviction Buy on Upcoming Drug Launches
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 221.56 +9.01 (4.24%)
Previous Close $212.55    52 Week High $333.65 
Open $215.33    52 Week Low $223.02 
Day High $222.15    P/E 28.37 
Day Low $215.08    EPS $7.81 
Volume 886,912